Meet the full Editorial Team behind Nutrition Insight.
HMOs and precision proteins push infant formula closer to breast milk
The nutrition industry is innovating in solutions for one of its most vulnerable consumer groups, infants. Nutrition Insight sits down with experts from Novonesis, Valio, Arla Foods Ingredients, and...
Novonesis says HMOs, biotics & social media reshape infant nutrition
Novonesis highlights that infant nutrition is increasingly focused on gut microbiome support, offering market opportunities for human milk oligosaccharides (HMOs) and Bifidobacteria. Social media and...
Viome acquires Sōlaria Biō to drive personalized nutrition beyond testing
Precision health company Viome has acquired the synbiotics and medical foods company Sōlaria Biō. The deal brings together Viome’s microbiome dataset with Sōlaria’s proprietary discovery platform and...
Botanic Healthcare’s Ironnox improves iron levels in women with anemia, clinical trial finds
Botanic Healthcare has announced new clinical findings for its iron ingredient Ironnox — a liposomal ferric pyrophosphate. The trial also showed no gastrointestinal-related adverse events from...
Review finds no clear link between GLP-1 use and adverse pregnancy outcomes in diabetes
A review investigating the impact of GLP-1 medications on pregnancy outcomes for women with diabetes has found that, in most cases, these drugs are not associated with poor outcomes. However, the...
SuanNutra unveils climate-adaptive lemon verbena cultivation project in Spain
SuanNutra has unveiled a sustainable approach to cultivating lemon verbena extract in Valencia, Spain. In a new project, the company collaborates with local parties to keep climate adaptation top of...
California signs health bills for non-UPF labels and bans weight-loss supplement sales for teens
California’s Governor, Gavin Newsom, has signed multiple bills to help consumers better access and identify nutritious products, including non-ultra-processed foods (UPFs), reducing high-sugar...
Semaglutide’s heart health benefits not solely explained by weight loss, trial finds
A new study has found that losing weight through the GLP-1 drug semaglutide may not be the sole reason for improvements in cardiovascular health linked to the medication. The researchers suggest...
